Influenza
Production ends on FluShield, Pnu-Imune vaccines
Published in TB and Outbreaks Week, January 7th, 2003
Adequate supplies of injectable flu vaccine are now available in the U.S. as a result of recent capacity increases provided by other manufacturers.
In addition, Wyeth has chosen to pursue new flu immunization technologies - specifically through its partnership with MedImmune to develop and market FluMist, an intranasal influenza vaccine. The focus on developing new vaccine products should result in better choices for physicians and patients, but requires a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Chlamydia
New team approach dramatically boosts chlamydia screening of teen-age girls - Infectious Disease Therapy
Azithromycin effective against Shiga toxin-producing E. coli - Infectious Disease Therapy
Cryptococcus neoformans protein triggers murine anticandidal activity - Infectious Disease Therapy
Yeast adhesin analogs can prevent intestinal C. albicans infection - Norwalk-like Virus
Inspections sharply reduce diarrhea outbreaks on cruise ships - Tuberculosis Pathogenesis
T helper 2 activity doesn't impair response to infection - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
